Archives — June 2016 back to current month (28)
Precious metals expert Michael Ballanger discusses market reactions post-Brexit vote.
Marc Faber: Holding Gold Is a 'No Brainer' (06/30/2016)
Brexit is a sideshow to the world economy, and gold remains an important asset in any portfolio, says Marc Faber, editor of the Gloom, Doom and Boom Report.
How Sick Will Brexit Make Biotech and Pharma? (06/29/2016)
In tandem with the broader markets, the biotech indices reeled on the news of Britain's vote to exit the European Union. Given the uncertainty and dire economic forecasts, The Life Sciences Report has reviewed commentary from sector experts and biotech publications to help investors understand what Brexit might mean for the industry.
The World Is Going to Pay for Brexit (06/26/2016)
Bob Moriarty discusses the reasons behind the Brexit vote and why governments need to change.
A Bull Market in Gold Is Now Confirmed (06/25/2016)
Gold rose sharply after Britain's Brexit vote and technical analyst Jack Chan has found that a new gold bull market has been confirmed.
Markets Roiled as Britain Votes Itself Out of EU (06/24/2016)
Britain has voted to exit the European Union and its prime minister has resigned in the wake of the Brexit vote. The markets have, so far, reflected the world's uneasy reaction to the event. But it is early days, says newsletter writer and technical analyst Clive Maund, who offers his views on the day after Brexit.
How the Brexit Vote Will Affect the Markets (06/23/2016)
Regardless the outcome of the Brexit vote, the European Union is failing, according to newsletter writer and technical analyst Clive Maund. The consequences will likely include a soaring dollar and a falling euro, market volatility and a slide in the prices of some commodities, but Maund has identified ways investors can profit from the chaos.
Klondex Finds Growth Opportunity in True North (06/23/2016)
Klondex Mines Ltd. released an update on the company's exploration and project development activities at its True North Gold mine, which was formerly known as the Rice Lake mine, in Manitoba, Canada. The company acquired the Canadian asset in January 2016.
Maxim analyst Jason McCarthy sees nothing but blue sky for Stellar Biotechnologies Inc., even though its product originated in the deep blue sea. With blockbuster indications like cancer, lupus and Alzheimer's disease being targeted by partners, and a manufacturing process sure to satisfy regulators, McCarthy lays out a value proposition for Stellar's KLH that investors should not ignore.
Are Copper and China Set to Rally? (06/21/2016)
Technical analyst and newsletter writer Clive Maund explores the link between an anticipated copper rally and an upswing in Chinese markets.
Is It Time to Dump Gold and Buy Platinum? (06/20/2016)
Bob Moriarty explains why precious metals investors may want to look beyond gold to a commodity with a long history and an interesting relationship to the yellow metal.
Oil Prices Send Sell Signal (06/20/2016)
Technical analyst Jack Chan believes a correction in oil prices is underway, and advises investors to use caution in a vulnerable market.
With both gold and silver ETFs trading in heavy volumes last week, technical analyst Jack Chan suspects liquidation is occurring, and speculates that the upcoming Brexit vote could impact the U.S. dollar.
Commercial Traders Have Just Gone Over the Top (06/18/2016)
Precious metals expert Michael Ballanger examines Friday's COT report and discusses its implication for investors.
NexGen Drilling Reveals Massive Pitchblende (06/17/2016)
Drilling has revealed massive pitchblende near NexGen Energy's Arrow zone on the Rook 1 property in the Athabasca Basin. Here's what the analysts have to say.
The Fed Giveth and the Bullion Banks Taketh Away… (06/16/2016)
Precious metal expert Michael Ballanger breaks down the gold price roller coaster surrounding the Fed's decision not to raise interest rates.
Soligenix Develops Defenses Against Bioterrorism (06/15/2016)
Maxim Group biotech analyst Jason Kolbert notes "steady progress" is being made by Soligenix Inc., a small-cap biotech with programs addressing bioterrorism threats and a devastating side effect of cancer treatment, in his Q1/16 update on the company.
George Soros Making Big Bets on Gold (06/11/2016)
George Soros has joined fellow billionaire investors Stan Druckenmiller and Ray Dalios on investing big in gold. Precious metals expert Michael Ballanger explains what is behind these moves.
The drill bit is essential to junior mining companies. Only through active exploration can investors separate the companies with potential from those without. Mick Carew of Haywood Securities discusses five companies on track to create value through the drill bit.
Investment in Cell and Gene Therapies Ramps Up (06/08/2016)
After decades of disappointment, cell therapies and gene therapies are finally seeing light at the end of the tunnel. Investors, investigators, clinicians, and patients with serious unmet needs are watching pivotal trials move into the home stretch. Yes. . .pivotal data are actually on the way.
Jobs Report Changes the Landscape for Gold (06/07/2016)
Gold soars as chances for a Fed rate hike this month evaporate. Brien Lundin, editor of Gold Newsletter, details what that means for investors.
Reservoir Minerals: A Rare Opportunity (06/06/2016)
Fund Manager Adrian Day has said that while Nevsun's acquisition of Reservoir Minerals would be a great deal for Nevsun and would create a new, well-financed mid-size base metals company, the offer undervalues Reservoir. Day discusses a rival proposal that has just come forth.
Two Rising Mining Companies for an Uncertain Market (06/06/2016)
The market has its moods and its fascination with headlines. Greece, Ukraine, ISIS, emerging markets—crises come and go. Investment adviser Jayant Bhandari discusses the role of gold in uncertain times and profiles two companies he believes have generated more value than their share price increase reflects or have gone unappreciated by the market.
Crude Oil Is Due for a Correction (06/06/2016)
Technical analyst Jack Chan demonstrates the divergence between oil equity prices and the underlying commodity.
Is the Gold Pullback Complete? (06/06/2016)
Technical analyst Jack Chan examines the charts after Friday's spike in gold.
After gold nearly reached $1,300/oz in early May, it has been trading lower, but Gwen Preston of Resource Maven is not worried. She sees this as the correction after the big gain and believes the new bull market is intact. In this article for The Gold Report, Preston discusses three companies that offer good opportunities in today's market.
Technical analyst and newsletter writer Clive Maund lists the reasons he believes oil prices, which recently peaked above $50/barrel, are headed for a fall.
Michael Ballanger, a precious metals expert, says he believes technical charts were created by bullion bank traders to lull the "chartists" into a false sense of security.
|"GPR is now authorized to construct the tailings storage facility."|
|"Adding Navilawa gives LIO many more targets to pursue."|
|"EFR is a good long-term bet on higher uranium prices."|
|"GSV intersected 0.89 g/t Au over 54.9m at the Jasperoid Wash target."|
|"R plans to start the San Ramon mill up again in January."|